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Abstract
The zinc ion (Zn2+) is abundant in neurons. However, excessive Zn2+ can induce neuronal cell death. This study examined the role of
Zn2+ in transient retinal ischemia in adult male rats. The rats were sacriWced 4–24 h after retinal ischemia by high intra-ocular pressure,
and the retinas were prepared for microscopic examination of retinal cell degeneration, and Xuorescence microscopy using zinquin ethyl
ester as the zinc ion-speciWc probe. Moreover, COX-2 expression was observed by Western blotting. In control retinas, there was a low
Zn2+ concentration in the inner plexiform layer (IPL), a high Zn2+ concentration in the outer plexiform layer (OPL), and no detectable
Zn2+ in either the ganglion cell layer (GCL) or the inner nuclear layer (INL). In contrast, in the retinas exposed to ischemia without the
administration of the zinc ion chelators (Ca2+-EDTA and TPEN), Zn2+ deposits were found in the IPL and INL beginning 4 h after ische-
mia and degeneration of neurons was found in the GCL and INL. Less Zn2+ accumulation in the IPL and INL and less neuronal degen-
eration in the GCL and INL were found in the retinas treated with Ca2+-EDTA or TPEN before ischemia. Furthermore, the COX-2
protein levels increased 4–8 h after retinal ischemia, and chelation of zinc ion inhibited this eVect. These results suggest that the accumula-
tion of Zn2+ following an ischemic insult can cause retinal degeneration and induce abnormal COX-2 expression.
© 2006 Elsevier Ltd. All rights reserved.
Abbreviations: Ca2+-EDTA, ethylenediaminetetraacetic acid saturated with equimolar Ca2+; TPEN, N,N,N,N tetrakis-(2 pyridylmethyl) ethylenedia-
mine; COX-2, cyclooxygenase 2
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Retinal ischemia induces neuronal degeneration in the
ganglion cell and inner nuclear layers and degeneration of
one or more types of retinal neurons leads to the loss of
vision. Ischemic retinopathy can cause the degeneration of
retinal neurons in glaucoma and diabetic retinopathy
(Levin, 2001).
In diabetic retinopathy, the loss of vision is due to
degeneration of the retinal neurons a result of a blockage of
* Corresponding author. Fax: +82 2 533 3801.
E-mail address: ckjoo@catholic.ac.kr (C.-K. Joo).0042-6989/$ - see front matter © 2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2006.02.014the blood supply. In glaucoma, the high-pressure in the eye-
ball also induces retinal ischemia and glutamate-related ret-
inal toxicity (Osborne et al., 2004). Neuronal cell
degeneration in retina and brain after ischemic injury
involves free radicalproductions, glutamate excitotoxicity,
and inXux of calcium and zinc (Choi, Weiss, Koh, Chris-
tine, & Kurth, 1989; Clemens, 2000; Joo et al., 1999).
Zinc ion (Zn2+) is essential for the formation, activation,
and regulation of the zinc metalloenzymes, superoxide dis-
mutase (SOD), and zinc Wnger protein (Frederickson, Suh,
Silva, & Thompson, 2000). Zinc ion modulates of neural
transmission and is reported to aVect gamma aminobutyric
acid (GABA), glycine, and NMDA receptor channels
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pell, & Ripps, 1997). It is present in the axon terminals of
the glutamatergic neurons in the central nervous system
(Franco-Pons et al., 2000) and it is abundant in the inner
segment of the photoreceptor cells of the retina and in reti-
nal pigment epithelium and at low concentrations in the
ganglion cell layer (GCL) and inner nuclear layer (INL)
(Akagi, Kaneda, Ishii, & Hashikawa, 2001; Grahn, Pater-
son, Gottschall-Pass, & Zhang, 2001; Ugarte & Osborne,
2001). Furthermore, zinc ions are actively controlled by the
pigment epithelium, and exogenous zinc ions increase the
catalase activity. Zn2+ concentration is very important for
metabolism in the retinal pigment epithelium, where it
plays a role in protection from oxidative stress (Miceli,
Tate, Alcock, & Newsome, 1999; Newsome, Oliver, Deup-
ree, Miceli, & Diamond, 1992).
However, zinc ion has been implicated in excitotoxic eVect
in the central nervous system, and plays a role in neuronal
degeneration. In addition, zinc ion induce cell death in neural
cell cultures and has been found to accumulate in neurons
after brain ischemia (Canzoniero, Manzerra, Sheline, & Choi,
2003; Kim, Kim, Gwag, Sohn, & Koh, 1999; Marin, Israel,
Glowinski, & Premont, 2000; Weiss, Sensi, & Koh, 2000). It
also accumulates in the ischemic retina and inhibits energy
production (Yoo, Lee, Lee, Koh, & Yoon, 2004).
There are three isoforms of cyclooxygenase (COX),
COX-1, COX-2, and COX-3. COX-1 is expressed constitu-
tively in most cells while COX-2 is only induced under
abnormal conditions. COX-3 is an alternatively spliced
form of COX-1 whose function is unclear. COX-2 is a pro-
inXammatory enzyme that is expressed after ischemic injury
to the brain and retina. COX-2 is known to be an early
response enzyme in neural ischemia (Dash, Mach, &
Moore, 2000; Hewett, Uliasz, Vidwans, & Hewett, 2000)
and its overexpression rapidly induces cell death (Dore
et al., 2003). Conversely, inhibition of COX-2 protects neu-
rons from neuronal cell death and inXammation (Ju, Kim,
& Neufeld, 2003; Sasaki et al., 2004).
The aim of this study was to examine the relationship
between the Zn2+ translocation and COX-2 expression
after retinal ischemia. We also assessed observed the eVect
of inhibiting Zn2+ translocation on ischemia-induced reti-
nal degeneration.
2. Materials and methods
2.1. Experimental animals
The subjects for this study were Sprague–Dawley rats (male, 200–250 g
each). All experiments adhered to the Principals of Laboratory Animal Care
(NIH Publication No. 86-23, revised 1985) and Institutional Animal Care
and Use Committee of the Catholic University of Korea. Rats were housed
under standard condition and anesthetized with xylazine (20 mg/kg, Yuhan
corp., Seoul, Korea). Retinal ischemia was induced in the left eye of rats by
application of high intra-ocular pressure (160 mmHg) for 1 h. The high
intra-ocular pressure was induced in anterior chamber by needle (30 guage,
Sigma, St. Louis, MO, USA) while observing a pressure meter. The right
eyes were used as non-ischemic controls after anesthetization.2.2. Degeneration of retinal neurons and labeling of RGCs
The eyes were Wxed in 4% paraformaldehyde for 2 h. The retinas were
embedded in paraYn after dehydration by alcohol. The paraYn-embed-
ded retinal tissues were sectioned at 6 m by microtome (Leica, Vienna,
Austria). After de-paraYn, sectioned tissues were stained for nuclear con-
densation (pyknotic cells) with Hoechst 33258 (2 g/ml in saline, Sigma)
and examined under Xuorescent microscopy (Carl Zeiss, Hallbergmoos,
Germany). We selected 10 retinas in each group for cell count in the exper-
imental retina. The number of cells was counted in a 500 £ 100 m square
of the GCL and of the INL and expressed as a percentage in each of the
Wve areas in selected from Wve diVerent retinas from each group.
For counting of retinal ganglion cells (RGCs), 4Di-10ASP (Molecular
Probe, Eugene, OR) was injected into the superior colliculus by the stereo-
taxic instrument with micro-injector (Stoelting, Wood dale, IL) at Wve
days before ischemia. 24 h after ischemia, the rats were sacriWced and eyes
were enucleated. The retinas were separated from the choroids and sclera,
and Xat-mounted on microscope slides. The labeled ganglion cells were
counted in a 0.5 £ 0.5 mm square under a Xuorescence microscope (Carl
Zeiss, Jena, Germany).
The number of cells was expressed as a percent of those seen in normal
retina. The data are expressed as value (mean § SEM). The statistical sig-
niWcance of diVerences in each group means was assessed using two-way
analysis of variance (ANOVA) and Student’s t test.
2.3. Chemical administration
As controls of ischemic experimental rats and non-ischemic control
eyes, 10 l (approximately one-third of vitreous volume) of 0.9% saline was
injected 10 min before induction of ischemia. Zinc translocation was inhib-
ited by Ca2+-EDTA (1 mM, extracellular zinc chelator, Sigma) and TPEN
(100 M, N,N,N,N tetrakis-(2 pyridylmethyl) ethylene diamine) (cell-per-
meable zinc chelator, Calbiochem, La Jolla, CA, USA). The Ca2+-EDTA
was dissolved in saline and the TPEN was dissolved in 10% DMSO. The
zinc chelators (10 l per eye) were injected into the vitreous body at 10 min
before induction of ischemia. The experimented rats were 10 animals in
each group. Rats were sacriWced 4–24 h after reperfusion by high dose
anesthetization.
2.4. Zinc ion accumulation assay
We used zinquin ethyl ester (Calbiochem) for detection of intracellular
zinc. After enucleating, the eyes were frozen on dry ice directly. The cryo-
embedded retinas were sectioned at 10 m, dried at room temperature, and
stained with zinquin ethyl ester (10 M, in DMSO) for 5 min at the dark
chamber. After rinsing in 0.9% saline, sections were examined under the
Xuorescence microscope with a diVerential interference contrast (DIC)
Wlter (Zeiss, Germany). The excitation and emission was 358 and 485 nm,
respectively. We selected 10 retinas in each group for analysis.
2.5. Western blot analysis for COX-2 expression
Retinas separated from eyeballs on an iced plate and retinas were
stored at ¡70 °C until use. The retinas were lysised for 10 min at 4 °C in
200 l of lysis buVer (20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EGTA,
1 mM EDTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
orthovanadate, 1 mM phenylmethylsulfonyl Xuoride, 1 g/ml leupeptin,
and 10 g/ml aprotinin). After homogenizing and centrifugation, the
supernatant was collected to total protein values. Twenty micrograms of
protein from each sample were loaded on SDS–polyacrylamide gel electro-
phoresis. After electrophoresis, the proteins were transferred to PVDF
membrane (Millipore, Bedford, MA, USA) at 350 mA for 70 min after
methanol activation. Antibody reaction was performed after blocking with
5% skim milk. The membrane was incubated with polyclonal rabbit anti-
COX-2 antibody (1:1000, Santa Cruz biotechnology, Santa Cruz, CA,
USA) overnight at 4 °C and washed three times in PBST (PBS containing
0.1% Twin 20) buVer. And then the membrane was incubated with
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biotech.) for 1 h. After three times washes with PBST buVer, HRP activity
was visualized on X-ray Wlm (Fuji Wlm, Tokyo, Japan) by Chemiluminis-
cence (ECL) (Western blotting luminol reagent (Santa Cruz biotech.)).
3. Results
3.1. Zinc accumulation after retinal ischemia
We have visualized the distribution of zinc with zinquin,
and have found that the location of zinc in the retina
changed after ischemia.
As shown in Fig. 1A, zinc was strongly concentrated in
the inner segment of the photoreceptor cells in the non-
ischemic control rats, and was not detected in either the
Fig. 1. Fluorescence microscopy of zinquin-stained Zn+ reveals co-locali-
zation of areas of retinal cell death and increased Zn+ concentrations. (A)
Non-ischemic control retina. (B) Ischemic control retina 4 h after reperfu-
sion. (C) DIC image of non-ischemic control retina. (D) DIC image show-
ing the presence of pyknotic cells in an ischemic control retina 4 h after
reperfusion. (E) Ca2+-EDTA (1 mM) treated ischemic experimental retina
4 h after reperfusion. (F) TPEN (100 M) treated ischemic experimental
retina 4 h after reperfusion. (G) and (H) DIC images of the sections in (E)
and (F), respectively. White arrows, Zn+: dark arrows, pyknotic cells;
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear
layer; OPL, outer plexiform layer; ONL, outer nuclear layer; IS, inner seg-
ment; OS, outer segment; RPE, retinal pigment epithelium. Scale
bar D 100 m.ONL or the INL. However, accumulation of zinc was
observed in both the IPL and INL beginning 4 h after ische-
mia and in GCL, zinc staining was stronger and more
diVuse than in the non-ischemic controls (Fig. 1).
The accumulation of zinc and the appearance of com-
pact, round pyknotic cells occurred in at the same locations
in the ischemic retinas (Figs. 1B and D). Pyknotic cells were
detected in the INL using light microscopy with a DIC
Wlter (Fig. 1D) and zinc was strongly concentrated in the
same areas (Fig. 1B). However, no pyknotic cells were
detected in the INL of the non-ischemic control retinas
(Fig. 1C). The accumulation of zinc and pyknotic cells was
inhibited by chelating zinc with 1 mM of Ca2+-EDTA (Figs.
1E and G) or 100M TPEN before inducing ischemia
(Figs. 1F and H). No eVect of 10% DMSO was not detected
on the retina.
3.2. Zinc chelation inhibits COX-2 expression
We also asked whether the accumulation of zinc induces
COX-2 expression (Fig. 2). Western blots of COX-2
(approximately 74 kDa) were performed 4, 8, and 24 h after
ischemia-reperfusion. Although low levels of COX-2 were
observed in the normal retina and control experiments
(Fig. 2E), COX-2 expression was increased from 4 h after
ischemia (Fig. 2A). And Ca2+-EDTA and TPEN inhibited
this eVect to similar extents (Fig. 2B). To conWrm the role of
zinc in COX-2 expression, we performed the experiments
shown in Figs. 2C and D, in which ZnCl2 (1 mM, 10l) was
injected into vitreous body as control experiments. Injec-
tion of ZnCl2 also induced COX-2 expression but induction
was greater at 24 h than 8 h (Figs. 2B and D). COX-2
expression was unaVected by Ca2+-EDTA and TPEN on
their own (Figs. 2E and F).
3.3. Inhibition of retinal degeneration by zinc chelators
To examine the relationship between retinal cell death
and zinc, we observed retinal cell death by staining with
Hoechst-33258 and retrograde labeling. Fig. 3A shows nor-
mal retinal neurons in the GCL and INL of the non-ische-
mic control retinas, and Fig. 3B shows degenerated retinal
neurons in the GCL and INL 24 h after ischemia from the
ischemic control retinas. Cells with pyknotic nuclei in the
GCL and INL are indicated by arrowheads in Fig. 3B.
Ca2+-EDTA (Fig. 3C) and TPEN (Fig. 3D) reduced retinal
degeneration in the GCL and INL 24 h after ischemia. In
ischemic retinas not injected with zinc chelators, 60 § 7% of
cells in the GCL and 47§ 5.2% of cells in the INL had
degenerated 24 h after reperfusion. With Ca2+-EDTA
(1 mM) pretreatment, only 17 § 5% of cells in the GCL and
21 § 5.5% of those in the INL had degenerated, and with
TPEN (100M) pretreatment, 22 § 7.5% of cells in the
GCL and 18 § 5% of those in the INL had degenerated
(Fig. 3E). Retrograde labeling of retinal ganglion cells
(RGCs) was performed to conWrm the protective eVect of
zinc chelators in the GCL (Fig. 4). In ischemic retina in the
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ber of RGCs were observed, and this number increased to
77 § 4.5% in the Ca2+-EDTA treated group (Fig. 4C) and to
74 § 5% in the TPEN treated group (Fig. 4D). The quanti-
tative data are given in Fig. 4E. In normal retinas, there
number were 687 § 21 RGCs per 0.5 mm2, and the chelators
signiWcantly inhibited retinal degeneration, (p < 0.05, vs.
ischemia without chelators). ANOVA and Student’s t testshowed that there was no diVerence between the protected
eVects of Ca2+-EDTA and TPEN.
4. Discussion
Neural ischemia raises glutamate level and activates
NMDA and kainate/AMPA receptors. High pressure-
induced retinal ischemia also causes release of glutamateFig. 2. Expression of COX-2 in ischemic retinas. Expression of COX-2 in response to ischemia (A and B) and exogenous ZnCl2 (C and D), with and with-
out prior treated of 1 mM Ca2+-EDTA and 100 M TPEN. (E and F) The data show control experiment. Each reagent did not induce COX-2 expression
8 h after treatment in normal retina. The data for each column in (B), (D), and (F) were taken from three diVerent experiments. The quantitative data were
obtained by densitometrc analysis, and are means § standard error (SEM).Fig. 3. Hoechst staining reveals retinal cell degeneration 24 h after ischemia. (A) A non-ischemic retina; (B) is an ischemic control retina; (C) is an ischemic
retina pretreated with Ca2+-EDTA; (D) is ischemic experimental retina pretreated with TPEN. Arrowheads indicate cells with pyknotic nuclei. Scale
bar D 50 m. The protective eVect of Zn+ chelator is shown in the form of quantitative data in (E) which are means § standard errors (SEM) of the num-
bers of cells remaining in the retina per 500 £ 100 m area 24 h after experimental ischemia with/without zinc chelators. Cell death (%) in the Zn+ chelator
treated groups was signiWcantly lower than in the non-treated group (p < 0.05 by ANOVAs).
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p53 (Choi et al., 1989). In addition, ischemic injury induces
cleavage of caspase and cause oxidative stress. In the ische-
mic condition, nitric oxide and lipid peroxidation are also
increased and the resulting accumulation of free radicals
lead to retinal cell death (Shibuki, Katai, Yodoi, Uchida, &
Yoshimura, 2000; Singh et al., 2001).
According to recent studies, ischemic injury is followed
by movement of zinc through NMDA channels, voltage-
gated calcium channels and Ca2+-A/K channels into the
post-synaptic neurons where it accumulates. These move-
ments of zinc have been conWrmed in kainate-induced
trauma models and ischemic models, both in vivo and
in vitro (Marin et al., 2000; Sensi, Yin, Carriedo, Rao, &
Weiss, 1999; Ugarte & Osborne, 2001). The accumulation
of zinc has been reported to induce cell death either by
reducing mitochondrial potential or increasing the concen-
tration of reactive oxygen species, and cell death is blocked
by superoxide dismutase (SOD)/catalase (Jiang, Sullivan,
Sensi, Steward, & Weiss, 2001; Pong, Rong, Doctrow, &
Fig. 4. Photomicrographs of retinal Xat-mounts. Retinal ganglion cells
were labeled retrogradely by injection of 4Di-ASP10 into the superior col-
liculus. (A) A normal retina, and (B) is a non-treated ischemic retina. The
density of RGCs in ischemic retinas treated with Ca+-EDTA (C) and
TPEN (D) is higher than in non-treated ischemic retina. The ganglion cells
in the temporal region were counted. (E) The viability of RGCs in the che-
lator treated ischemic retinas is signiWcantly diVerent from that of the
non-treated ischemic retinas. The normal retina is set at 100%. *p < 0.01
by ANOVAs. Scale bar D 50 m.Baudry, 2002; Sheline, Behrens, & Choi, 2000; Weiss et al.,
2000). Zinc-induced cell death involves some types of intra
cellular signaling events such as cleavage of PARP, modu-
lation of caspase, and depletion of glutathione (GSH)
which reduces oxidative stress in neurons. In addition, zinc-
induced cell death is blocked by treatment with GSH and
pyruvate (Chen & Liao, 2003; Kim & Koh, 2002; Marini
et al., 2001). On the other hand, zinc is reported have a pro-
tective eVect as a free radical scavenger (Chimienti, Seve,
Richard, Mathieu, & Favier, 2001; Dominguez, Blasco-Iba-
nez, Crespo, Marques-Mari, & Martinez-Guijarro, 2003). It
has been proposed that synaptic zinc plays the role of an
anti-cell death ion in the case of neuronal damage, in vitro
and in vivo. According to these reports, chelation of zinc
increases neuronal degeneration in response to excitotoxic
reagents, and addition of a low concentration of zinc
reduced excitotoxic cell death. Moreover, depletion of zinc
results in neuronal degeneration in the normal. Therefore,
zinc appears to have important bioactivity in both the neu-
ronal degeneration and the normal condition.
Increased cyclooxygenase-2 (COX-2) level induces
inXammation and cell death in ischemia. COX-2 expression
was induced by neuronal ischemia and glutamate or gluta-
mate agonists (NMDA and kinate) (Consilvio, Vincent, &
Feldman, 2004; Hewett et al., 2000). In the retina, COX-2 is
expressed in ischemic conditions such as glaucoma, retinal
neovascularization and retinal proliferative retinopathy
(Sennlaub et al., 2003; Yuan & Neufeld, 2001). It was
detected in retinal ganglion cells and amacrine cells after
ischemia. (Ju et al., 2003).
We conWrmed above that zinc accumulation was con-
Wrmed in the IPL and INL following retinal ischemia, and
that areas of zinc accumulations co-localize with degenerat-
ing cells in the ischemic retina (Fig. 1). In addition, we
detected a role of zinc accumulation in retinal degeneration
(Figs. 2–4). Our results indicate that inhibiting the intracel-
lular accumulation of zinc tends to inhibit ischemia-medi-
ated neuronal degeneration.
We used the cell-permeable zinquin ethyl ester to detect
zinc ions. This chemical is speciWc for zinc ions and is easy
to use. The zinquin is hydrolyzed within the cells and then
binds to free zinc. Zinc has also been detected in neurons of
the hippocampus using zinquin (Kimber, Mahadevan, Lin-
coln, Ward, & Tiekink, 2000; Snitsarev et al., 2001). Ca2+-
EDTA and TPEN were used to inhibit of zinc translocation
in this study. The Ca2+-EDTA used was calcium saturated
to chelate metal ions, and TPEN (N,N,N,N tetrakis-(2
pyridylmethyl) ethylenediamine) has a high aYnity for zinc,
copper, and iron ions and a low aYnity for calcium ion.
Ca2+-EDTA is water-soluble but TPEN is not. However,
TPEN is a cell-permeable zinc ion chelator (Canzoniero
et al., 2003; Frederickson et al., 2002; Shumaker, Vann,
Goldberg, Allen, & Wilson, 1998). We found that Ca2+-
EDTA and TPEN had similar eVect on retinal neuropro-
tectine eVects.
Our Wndings suggest that endogenous zinc ion induces
COX-2 expression in neural and retinal ischemia. However,
2726 J.-S. Choi et al. / Vision Research 46 (2006) 2721–2727the relationship between the free zinc and COX-2 expres-
sion requires further study.
In conclusion, the accumulation of zinc ions in retinal
neurons is one of the causes of retinal degeneration and of
COX-2 expression after retinal ischemia. Over accumula-
tion of Zn+ may be an indicator of degeneration of retinal
neurons in abnormal conditions.
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